Table of Contents
- How EPR Applies to Pharmaceutical Packaging
- Obligation Thresholds for Pharma
- Common Pharmaceutical Packaging Types
- EPR Fees for Pharma Packaging
- Regulatory Constraints on Packaging Changes
- Data Collection in Pharma
- Strategies to Manage EPR Costs
- Key Takeaways
Key Takeaways
- Pharmaceutical companies are not exempt from packaging EPR — medicine packaging, blister packs, and outer cartons all count towards your obligations.
- MHRA-regulated packaging cannot be easily changed to reduce EPR costs, limiting some optimisation strategies available to other industries.
- Blister packs (aluminium/PVC composite) attract high EPR fees at up to £461 per tonne for multi-material packaging.
- Large pharmaceutical companies must report nation data, splitting packaging tonnage across England, Scotland, Wales, and Northern Ireland.
- Hospital and clinical supply chains create additional complexity for tracking transit and secondary packaging.
How EPR Applies to Pharmaceutical Packaging
Extended Producer Responsibility for packaging applies to all businesses that produce, import, or sell packaged goods in the UK — and the pharmaceutical industry is no exception. Every tablet blister, every medicine carton, every patient information leaflet, and every transit box must be accounted for under the EPR regime.
The pharmaceutical sector faces a unique challenge: much of its packaging is designed to meet strict regulatory requirements set by the Medicines and Healthcare products Regulatory Agency (MHRA). Changing packaging to reduce EPR costs often requires regulatory approval, adding time and expense to any optimisation effort.
For background on the full EPR framework, see what packaging EPR is and how it works.
Obligation Thresholds for Pharma
The standard thresholds apply:
- Annual turnover of £1 million or more
- Handle 25 or more tonnes of packaging per year
Almost every pharmaceutical company of commercial scale will exceed both thresholds. Even a small generics manufacturer producing a few product lines will typically handle well over 25 tonnes of packaging annually when transit packaging is included.
For full threshold details, see who needs to register for packaging EPR.
Common Pharmaceutical Packaging Types
Primary Packaging (in direct contact with the product)
- PVC/aluminium blister packs — the most common oral solid dose format
- HDPE bottles — for tablets and capsules
- Glass vials and ampoules — for injectables
- Aluminium tubes — for creams and ointments
- Foil sachets — for powders and granules
- PET or HDPE bottles — for liquid medicines
Secondary Packaging
- Printed cardboard cartons — the branded outer box
- Patient information leaflets (PIL) — paper inserts (these count as packaging)
- Labels — self-adhesive paper or plastic labels
Transit Packaging
- Corrugated cardboard boxes — outer shipping cases
- Pallet wrap — stretch film for pallet loads
- Cold chain packaging — insulated boxes, gel packs, dry ice containers
- Void fill — bubble wrap, air pillows, paper fill
Classification Notes
Under EPR, patient information leaflets are classified as packaging (not a product) because they are enclosed with the medicine. This is an important point that some pharmaceutical companies overlook.
EPR Fees for Pharma Packaging
| Material | Fee per tonne (approx.) | Pharma Use |
|---|---|---|
| Paper/card | £215 | Cartons, PILs, labels |
| Aluminium | £230 | Blister foils, tubes |
| Glass | £192 | Vials, bottles |
| Plastic (HDPE/PET) | £360 | Bottles, caps |
| PVC/alu composite | £461 | Blister packs |
| Plastic film | £360 | Overwrap, pallet wrap |
Blister packs are a particular cost driver. A PVC/aluminium blister is a multi-material composite and attracts the highest fee rate. For a company producing millions of blister packs, this adds up quickly.
For full fee details, see our EPR fees by material type guide.
Regulatory Constraints on Packaging Changes
Unlike most industries, pharmaceutical companies cannot simply redesign their packaging to reduce EPR costs. Key constraints include:
MHRA Approval Requirements
- Any change to primary packaging requires a variation application to the MHRA
- Changes to secondary packaging (carton size, leaflet format) may also require notification
- Approval timelines can be 6-12 months for packaging changes
- Stability testing may be required for new primary packaging materials
Child-Resistant and Tamper-Evident Requirements
- Many medicines require child-resistant closures (CRCs)
- Tamper-evident features add packaging weight and complexity
- These are non-negotiable safety requirements
Serialisation and Track-and-Trace
- The Falsified Medicines Directive (FMD) requires unique identifiers on secondary packaging
- This constrains carton design and printing specifications
What You CAN Change
- Transit packaging — no regulatory constraints; optimise freely
- Void fill and pallet wrap — choose lighter-weight options
- Outer case quantities — pack more units per case to reduce per-unit transit packaging
- Unregulated products — OTC products with fewer regulatory constraints may be easier to optimise
Data Collection in Pharma
Pharmaceutical companies generally have excellent packaging data because regulatory submissions require detailed packaging specifications. Leverage this existing data:
- Use your regulatory affairs database — packaging component lists are already documented for every product
- Cross-reference with production data — batch records show exactly how many units were produced
- Map your supply chain — identify where packaging is added (contract manufacturers, distributors, cold chain providers)
- Track nation data — use wholesale distribution data to split volumes across the four UK nations
Contract Manufacturing
If you use contract manufacturers who pack your products, clarify who holds the EPR obligation:
- If the CMO packs goods under your brand name, you are typically the obligated party
- If the CMO packs goods under their own arrangements, they may hold the obligation for the packaging they supply
Get written confirmation of EPR responsibility in your CMO agreements.
For guidance on reporting, see how to report packaging data to DEFRA.
Strategies to Manage EPR Costs
1. Optimise Transit Packaging
Transit packaging is the easiest area to improve since it has no regulatory constraints. Right-size your shipping cases, reduce void fill, and consider returnable transit packaging for hospital supply chains.
2. Review Blister Pack Design
While changing blister materials requires MHRA approval, it may be worth the investment for high-volume products. Options include:
- PVC-free blisters (e.g., cold-form aluminium) — may classify differently
- Thinner PVC gauges where stability data supports it
- Fewer blisters per pack — consider different pack sizes
3. Reduce Leaflet Size
Patient information leaflets can be surprisingly heavy in aggregate. Consider:
- Thinner paper grades (subject to readability requirements)
- Electronic leaflets where regulations allow
- Optimised folding to reduce paper area
4. Consolidate Packaging Data
Pharmaceutical companies often have multiple sites and contract manufacturers. Consolidate your packaging data into a single system to ensure accurate reporting and identify optimisation opportunities across your portfolio.
5. Plan for Mandatory Labelling (2027)
From 2027, EPR mandatory labelling requirements will apply. For pharmaceutical companies, this will require additional regulatory planning. Start assessing the impact now.
Hospital and Clinical Supply Chains
Pharmaceutical companies supplying hospitals and clinics face additional complexity:
- Bulk hospital packs have different packaging profiles than retail packs
- Cold chain products require insulated transit packaging that may include plastic inserts, gel packs, and insulated liners
- Clinical trial supplies have unique packaging requirements
Ensure your data collection captures all supply chain channels, not just retail pharmacy distribution.
Getting Started
- Verify your obligation status using the EPR compliance checklist
- Audit your packaging portfolio — leverage existing regulatory packaging data
- Register with a compliance scheme or directly with the Environment Agency
- Submit packaging data through DEFRA’s RPD portal
- Identify quick wins in transit packaging while planning longer-term primary packaging optimisation
Use our EPR fee calculator to estimate your costs, and visit our pricing page for compliance management tools.